Literature DB >> 8246614

The incidence and prevalence of congestive heart failure in Rochester, Minnesota.

R J Rodeheffer1, S J Jacobsen, B J Gersh, T E Kottke, H A McCann, K R Bailey, D J Ballard.   

Abstract

Although congestive heart failure is a fairly common clinical syndrome and the societal costs associated with its care are high, relatively little is known about the incidence or prevalence of the condition in the community. Using the resources of the Rochester Epidemiology Project, we identified all 46 persons 0 through 74 years of age who had a new diagnosis of congestive heart failure during 1981 and all 113 persons with a prevalent diagnosis on Jan. 1, 1982, in the city of Rochester, Minnesota. After confirming the diagnosis in the medical record by using criteria similar to those in the Framingham study, we found the annual incidence of congestive heart failure to be 110 per 100,000 after adjusting for age. Incidence rates were higher among male than among female study subjects (157 versus 71 per 100,000). In both male and female subjects, the incidence generally increased with advancing age, reaching 1,618 per 100,000 and 981 per 100,000, respectively. Prevalence rates on Jan. 1, 1982, demonstrated similar patterns. Overall, the prevalence of congestive heart failure was higher among male than among female subjects (327 versus 214 per 100,000) and increased exponentially with advancing age, reaching almost 3% in both sexes. Survival after a diagnosis of congestive heart failure was extremely poor, with only 80% alive at 3 months and 66% at 1 year. These data underscore the effect of congestive heart failure in the community and provide estimates of the number of persons who might benefit from early intervention.

Entities:  

Mesh:

Year:  1993        PMID: 8246614     DOI: 10.1016/s0025-6196(12)60063-9

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

Review 1.  Preventing clinical heart failure: the rationale and scientific evidence.

Authors:  D A Wood
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 2.  A systematic review of validated methods for identifying heart failure using administrative data.

Authors:  Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

3.  Classification of heart failure in population based research: an assessment of six heart failure scores.

Authors:  A Mosterd; J W Deckers; A W Hoes; A Nederpel; A Smeets; D T Linker; D E Grobbee
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

4.  Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial.

Authors:  Ali Ahmed; Wilbert S Aronow; Jerome L Fleg
Journal:  Am J Ther       Date:  2006 Jul-Aug       Impact factor: 2.688

5.  Epidemiological burden of heart failure.

Authors:  L Tavazzi
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

6.  Summary of scientific evidence.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  2002-02

Review 7.  Community management of heart failure.

Authors:  R S McKelvie
Journal:  Can Fam Physician       Date:  1998-12       Impact factor: 3.275

Review 8.  Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.

Authors:  D J van Kraaij; R W Jansen; F W Gribnau; W H Hoefnagels
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

9.  Novel strategies for the detection of systolic and diastolic heart failure.

Authors:  Cara Lodewijks-Vd Bolt; Leo Baur; Jelle Stoffers; Timo Lenderink; Ron Winkens
Journal:  Curr Cardiol Rev       Date:  2009-05

10.  Are there sex-related differences in specialized, multidisciplinary congestive heart failure clinics?

Authors:  Stefanie Houde; Debbie Ehrmann Feldman; Louise Pilote; Eduard J Beck; Nadia Giannetti; Marc Frenette; Anique Ducharme
Journal:  Can J Cardiol       Date:  2007-05-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.